Examples of Formulation Patent in a sentence
In no event shall more than one such royalty be due Unigene hereunder with respect to the sale of each Licensed Product, even if such Licensed Product is covered by more than one Valid Claim within the Unigene Formulation Patent Rights.
There are no other patents licensed to ATL pursuant to the ISIS Agreement, including without limitation, the ISIS Formulation Patent Rights, Research Target Patent Rights or any other ISIS Patent Rights (as such terms are defined in the ISIS Agreement) that are necessary or useful to Exploit the Technology in the Field in the Territory for the Purpose.
Where Substantial Equivalent Competition by an Equivalent Product exists in a country in which a Licensed Product covered by a Valid Claim of Unigene Formulation Patent Rights is being sold, the applicable royalties set forth in Section 3.4.1 on Net Sales in such country shall be reduced by *** percent (***%) for each Calendar Quarter in which Substantial Equivalent Competition exists.
In the event Section 3.4.3 does not apply, where Substantial Similar Competition by a Similar Product exists in a country in which a Licensed Product covered by a Valid Claim of Unigene Formulation Patent Rights is being sold, the applicable royalties set forth in Section 3.4.1 on Net Sales in such country shall be reduced by *** percent (***%) for each Calendar Quarter in which Substantial Similar Competition exists.
In the event that no royalty on certain Net Sales is paid under Section 3.4 because the Licensed Product for sale is not covered by a Valid Claim of Unigene Formulation Patent Rights, then as further consideration for the licenses granted to GSK under Section 2.1 of this Agreement, GSK shall pay to Unigene *** percent (***%) of the otherwise applicable royalty rate set forth in Section 3.4.1 on such Net Sales.
Formulation Patent has been issued and will add protection through 2036.
The obligation of GSK to pay royalties under Section 3.4 shall continue for each Licensed Product on a Licensed Product-by-Licensed Product and country-by-country basis, until such time as there are no Valid Claims of Unigene Formulation Patent Rights covering the manufacture, sale or use of such Licensed Product in such country.
Brand Title: President & CEO Title: President/CEO Schedule 1 Part I Assigned Contracts *** Part II Retained Agreements *** Schedule 2 Licensed Patent Rights Licensed Calcitonin Formulation Patent Rights *** Licensed Calcitonin Manufacturing Patent Rights and Licensed *** Patent Rights *** Schedule 3 *** Specifications *** Schedule 4 Development Timeline *** Schedule 5 Form of Calcitonin IND Assignment Xxxxx X.
Royalty obligations under Section 3.4 in each country of the Territory shall expire upon the expiration or invalidation of the last remaining issued Unigene Formulation Patent Right in such country, which claims the Licensed Product sold.
Xxxxxx Title: President & Chief Executive Officer Title: Vice President & Secretary APPENDIX A UNIGENE PATENT RIGHTS I Unigene Formulation Patent Rights (including Patent Applications) Title/Description (Inventors) Country Application No. Application Date Patent No. Grant Date Normal Expiration Date (not including term extension) *** 1 ____________________________ CONFIDENTIAL Unigene Laboratories, Inc.